MassMutual Private Wealth & Trust, FSB
Position in NKTR — Nektar Therapeutics
CIK 1103653
Windsor, CT
Position in NKTR
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$7,399
+$1,787 QoQ
Shares Held
106
+35.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#216
of 239 holders
Holding Since
Dec 2021
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MassMutual Private Wealth & Trust, FSB holds $21,953,680 across 115 Biotechnology names. NKTR ranks #46 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
28,385 | $14,099,681 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
9,576 | $5,971,019 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
10,629 | $414,637 | |
| 4 | INCY |
Incyte Corp
|
1,311 | $148,614 | |
| 5 | MRNA |
Moderna, Inc.
|
1,817 | $127,244 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,697 | $92,333 | |
| 7 | RPRX |
Royalty Pharma plc
|
1,396 | $78,273 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
283 | $68,194 |
All Filings in NKTR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,399 | 106 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $5,612 | 78 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $1,902 | 45 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $3,641 | 64 | Shares | Sole | 2025-10-22 | |
| 2022-12-31 | $2 | 793 | Shares | Sole | 2023-01-06 | |
| 2022-09-30 | $1,852 | 579 | Shares | Sole | 2022-10-07 | |
| 2021-12-31 | $2,080 | 154 | Shares | Sole | 2022-02-09 | |
| No filing history on record for this holder in this stock. | ||||||